The in vitro approach revealed that EC-synthetic retinoids, especially EC19, hold promise as an effective strategy for the treatment of cancer-based on their significant effects in reducing ATPase activity and ABC transporters and inducing DNA fragmentation, apoptosis and necrosis. The gene discussed is DNAH8; the disease is cancer.